Scientific Sessions 2024  /  Meet the Trialists: nex-Z and BPROAD  /  Meet the Trialist: Nexiguran ziclumeran (nex-z, also known as NTLA-2001), an investigational in vivo CRISPR-based therapy for patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM): interim report of the Phase 1 study
Logo

American Heart Association

  11
  0

Final ID:

Meet the Trialist: Nexiguran ziclumeran (nex-z, also known as NTLA-2001), an investigational in vivo CRISPR-based therapy for patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM): interim report of the Phase 1 study

  • Fontana, Marianna  ( University College London , London , United Kingdom )
    • Author Disclosures:
    Marianna Fontana: DO have relevant financial relationships ; Consultant:Dr. Fontana reports consultancy/advisory boards for Alnylam, Alexion/Caelum Biosciences, Astrazeneca, Bridgbio/Eidos, Prothena, Attralus, Intellia Therapeutics, Ionis Pharmaceuticals, Cardior, Lexeo Therapeutics, Janssen Pharmaceuticals, Prothena, Pfizer, Novonordisk, Bayer, Mycardium. Research grants from: Alnylam, Bridgbio, Astrazeneca, Pfizer. Salary from British Heart Foundation Intermediate Fellowship. Share options in LexeoTherapeutics and shares in Mycardium.:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Meet the Trialists: nex-Z and BPROAD

Saturday, 11/16/2024 , 03:15PM - 04:00PM

Meet the Trialist

More abstracts on this topic:
Meet the Trialist: BPROAD: Effects of Intensive Blood Pressure Control in Patients with Type 2 Diabetes

Ning Guang

More abstracts from these authors:
Impact of vutrisiran on outpatient worsening heart failure in patients with transthyretin amyloidosis with cardiomyopathy in the HELIOS-B trial

Fontana Marianna, Maurer Mathew, Gillmore Julian, Bender Shaun, Aldinc Emre, Eraly Satish, Jay Patrick, Solomon Scott

Stiffen Up: Evaluation of HFpEF in the Patient with Cancer

Fontana Marianna, Sarswat Nitasha, Ruberg Frederick

You have to be authorized to contact abstract author. Please, Login
Not Available